BioNTech SE
(NASDAQ : BNTX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. 1.60%78.211.0%$1948.71m
AMGNAmgen, Inc. -1.66%205.411.3%$885.20m
REGNRegeneron Pharmaceuticals, Inc. -1.09%493.322.6%$821.01m
BIIBBiogen, Inc. -1.30%300.511.5%$730.72m
MRNAModerna, Inc. 4.94%34.840.0%$587.89m
VRTXVertex Pharmaceuticals, Inc. -1.59%238.311.9%$585.26m
ILMNIllumina, Inc. -3.48%263.503.5%$455.53m
ALXNAlexion Pharmaceuticals, Inc. -0.64%89.772.0%$278.42m
AAgilent Technologies, Inc. -2.63%70.391.6%$217.41m
INCYIncyte Corp. 1.97%78.592.5%$187.57m
EXASEXACT Sciences Corp. -3.21%55.7521.0%$173.77m
BMRNBioMarin Pharmaceutical, Inc. -2.15%84.214.3%$161.37m
SGENSeattle Genetics, Inc. -1.82%116.516.1%$157.34m
NVAXNovavax, Inc. 12.63%15.61114.7%$131.54m
SRPTSarepta Therapeutics, Inc. -2.46%93.6214.0%$100.23m

Company Profile

BioNTech SE operates as a clinical-stage biotechnology company. It operates through the following business units: Biotech Business and External Services. The Biotech Business unit consists of Clinical, Technology Platform and Manufacturing segments. It also includes business services operations. The External Services unit consists of External Services segment, which includes activities related to the sale of diagnostic products, peptides, retroviral vectors for clinical supply, development and manufacturing services. The company was founded by Christopher Huber, Ozlem Tureci and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.